These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34437819)

  • 1. Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis.
    Li B; Zhang J; Chen Y; Wang Q; Yan L; Wang R; Wei Y; You Z; Li Y; Miao Q; Xiao X; Lian M; Chen W; Qiu D; Fang J; Gershwin ME; Tang R; Ma X
    Gut Microbes; 2021; 13(1):1946366. PubMed ID: 34437819
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network.
    Guo Z; He K; Pang K; Yang D; Lyu C; Xu H; Wu D
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-causal inference based on multi-omics data reveals the association of altered gut bacteria and bile acid metabolism with neonatal jaundice.
    Chen W; Zhang P; Zhang X; Xiao T; Zeng J; Guo K; Qiu H; Cheng G; Wang Z; Zhou W; Zeng S; Wang M
    Gut Microbes; 2024; 16(1):2388805. PubMed ID: 39166704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid.
    Han W; Huang C; Zhang Q; Tao S; Hu X; Xu J; Jiang R; Xu B; Liu Y; Hou J
    Eur J Clin Invest; 2022 Feb; 52(2):e13714. PubMed ID: 34800290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC.
    Jiang H; Yu Y; Hu X; Du B; Shao Y; Wang F; Chen L; Yan R; Li L; Lv L
    Gut Microbes; 2024; 16(1):2383353. PubMed ID: 39105259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome-Metabolomics Analysis of the Impacts of
    Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
    Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis.
    Umemura M; Honda A; Yamashita M; Chida T; Noritake H; Yamamoto K; Honda T; Ichimura-Shimizu M; Tsuneyama K; Miyazaki T; Kurono N; Leung PSC; Gershwin ME; Suda T; Kawata K
    J Autoimmun; 2024 Sep; 148():103287. PubMed ID: 39033687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
    Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome pattern impacts treatment response in primary biliary cholangitis.
    Liu Q; Huang B; Zhou Y; Wei Y; Li Y; Li B; Li Y; Zhang J; Qian Q; Chen R; Lyu Z; Wang R; Cao Q; Xu Q; Wang Q; Miao Q; You Z; Lian M; Gershwin ME; Jin Q; Xiao X; Ma X; Tang R
    Med; 2024 Sep; ():. PubMed ID: 39305900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
    Hegade VS; Pechlivanis A; McDonald JAK; Rees D; Corrigan M; Hirschfield GM; Taylor-Robinson SD; Holmes E; Marchesi JR; Kendrick S; Jones DE
    Liver Int; 2019 May; 39(5):967-975. PubMed ID: 30735608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis.
    Lammert C; Shin A; Xu H; Hemmerich C; O'Connell TM; Chalasani N
    FEMS Microbiol Lett; 2021 Apr; 368(6):. PubMed ID: 33836051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.
    Tang R; Wei Y; Li Y; Chen W; Chen H; Wang Q; Yang F; Miao Q; Xiao X; Zhang H; Lian M; Jiang X; Zhang J; Cao Q; Fan Z; Wu M; Qiu D; Fang JY; Ansari A; Gershwin ME; Ma X
    Gut; 2018 Mar; 67(3):534-541. PubMed ID: 28213609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes.
    Zheng Y; Ran Y; Zhang H; Wang B; Zhou L
    Front Physiol; 2021; 12():715852. PubMed ID: 34690796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota.
    Rodriguez J; Neyrinck AM; Zhang Z; Seethaler B; Nazare JA; Robles Sánchez C; Roumain M; Muccioli GG; Bindels LB; Cani PD; Maquet V; Laville M; Bischoff SC; Walter J; Delzenne NM
    Gut Microbes; 2020 Nov; 12(1):1810530. PubMed ID: 32893709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
    Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
    J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
    Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
    Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.